Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

EM VivasSubarachnoid haemorrhage

EM Vivas · Subarachnoid haemorrhage

Subarachnoid haemorrhage — diagnosis, grading and complications

A clinical viva on SAH diagnostics, grading, and secondary complications.

clinical1 min readSource-verified ·

Target exams

ACEMFRCEMABEM
On this page
Study tools

Target exams

ACEMFRCEMABEM
Prompt
A 52-year-old smoker has a thunderclap headache. CT confirms diffuse SAH. Discuss grading systems, the role of LP when CT is negative, nimodipine, and the management of delayed cerebral ischaemia.

Interpretation

Reveal interpretationShowHide

Grading. Admission clinical condition is described with the Hunt and Hess and WFNS scales. The modified Fisher scale predicts symptomatic vasospasm — odds ratio 2.2 for grade 4 versus grade 0-1.[1][2] LP when CT is negative. CT sensitivity overall was 92.9% (100% within 6 hours). If CSF is examined, spectrophotometry was 100% sensitive versus 73% for visual inspection.[3][4] Nimodipine. Oral nimodipine 60 mg four-hourly reduced infarction (22 vs 33%) and poor outcome (20 vs 33%); in the Cochrane review oral nimodipine reduced poor outcome (RR 0.67) but intravenous nimodipine did not reach significance.[5][6] DCI. Defined by cerebral infarction on imaging and functional outcome, with clinical deterioration secondary. Induced hypertension is unproven — the only RCT showed no benefit and more serious adverse events. Statins (STASH) did not help, and ESO recommends against statins, magnesium and endothelin antagonists.[7][8][9][1]

Emergency Medicine Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Emergency Medicine fellowship library.

Sign in to continueSee pricing
References9ShowHide
  1. [1]Vergouwen MDI, Ramos-Pachon A, Terecoasa EO, et al. European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. European stroke journal, 2026.PMID 42095754
  2. [2]Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery, 2006.PMID 16823296
  3. [3]Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ (Clinical research ed.), 2011.PMID 21768192
  4. [4]Sjulstad AS, Brekke OL, Alstadhaug KB Visual inspection versus spectrophotometry for xanthochromia detection in patients with sudden onset severe headache-A diagnostic accuracy study. Headache, 2025.PMID 39087907
  5. [5]Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (Clinical research ed.), 1989.PMID 2496789
  6. [6]Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. The Cochrane database of systematic reviews, 2007.PMID 17636626
  7. [7]Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke, 2010.PMID 20798370
  8. [8]Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. Stroke, 2018.PMID 29158449
  9. [9]Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. The Lancet. Neurology, 2014.PMID 24837690
Emergency Medicine Pro

$29/ monthor $279 / year

The complete Emergency Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousStingray injury — the data vivaToxicology and environmental emergenciesNextSyncope — the differential and the risk stratificationSyncope (approach)